These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 26981577)

  • 1. Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh.
    Sarker SA; Sultana S; Reuteler G; Moine D; Descombes P; Charton F; Bourdin G; McCallin S; Ngom-Bru C; Neville T; Akter M; Huq S; Qadri F; Talukdar K; Kassam M; Delley M; Loiseau C; Deng Y; El Aidy S; Berger B; Brüssow H
    EBioMedicine; 2016 Feb; 4():124-37. PubMed ID: 26981577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh.
    Sarker SA; Berger B; Deng Y; Kieser S; Foata F; Moine D; Descombes P; Sultana S; Huq S; Bardhan PK; Vuillet V; Praplan F; Brüssow H
    Environ Microbiol; 2017 Jan; 19(1):237-250. PubMed ID: 27750388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From bench to bed and back again: phage therapy of childhood Escherichia coli diarrhea.
    Sarker SA; Brüssow H
    Ann N Y Acad Sci; 2016 May; 1372(1):42-52. PubMed ID: 27197768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Escherichia coli bacteriophages from the stool of pediatric diarrhea patients in Bangladesh.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Dillmann ML; Kutter E; Qadri F; Sarker SA; Brüssow H
    J Bacteriol; 2004 Dec; 186(24):8287-94. PubMed ID: 15576777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative polymerase chain reaction assay for rapid detection of 9 pathogens directly from stools of travelers with diarrhea.
    Antikainen J; Kantele A; Pakkanen SH; Lääveri T; Riutta J; Vaara M; Kirveskari J
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1300-1307.e3. PubMed ID: 23639597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.
    Bruttin A; Brüssow H
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2874-8. PubMed ID: 15980363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails.
    Bourdin G; Navarro A; Sarker SA; Pittet AC; Qadri F; Sultana S; Cravioto A; Talukder KA; Reuteler G; Brüssow H
    Microb Biotechnol; 2014 Mar; 7(2):165-76. PubMed ID: 24528873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T4 phages against Escherichia coli diarrhea: potential and problems.
    Denou E; Bruttin A; Barretto C; Ngom-Bru C; Brüssow H; Zuber S
    Virology; 2009 May; 388(1):21-30. PubMed ID: 19339031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial.
    Casswall TH; Sarker SA; Faruque SM; Weintraub A; Albert MJ; Fuchs GJ; Alam NH; Dahlström AK; Link H; Brüssow H; Hammarström L
    Scand J Gastroenterol; 2000 Jul; 35(7):711-8. PubMed ID: 10972174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of main diarrheagenic Escherichia coli, with emphasis on enteroaggregative E. coli, in severe non-epidemic pediatric diarrhea in a high-income country.
    Tobias J; Kassem E; Rubinstein U; Bialik A; Vutukuru SR; Navaro A; Rokney A; Valinsky L; Ephros M; Cohen D; Muhsen K
    BMC Infect Dis; 2015 Feb; 15():79. PubMed ID: 25887696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh.
    Sarker SA; McCallin S; Barretto C; Berger B; Pittet AC; Sultana S; Krause L; Huq S; Bibiloni R; Bruttin A; Reuteler G; Brüssow H
    Virology; 2012 Dec; 434(2):222-32. PubMed ID: 23102968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.
    Chibani-Chennoufi S; Sidoti J; Bruttin A; Kutter E; Sarker S; Brüssow H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2558-69. PubMed ID: 15215109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology of acute diarrhea in children and adults in Tunis, Tunisia, with emphasis on diarrheagenic Escherichia coli: prevalence, phenotyping, and molecular epidemiology.
    Al-Gallas N; Bahri O; Bouratbeen A; Ben Haasen A; Ben Aissa R
    Am J Trop Med Hyg; 2007 Sep; 77(3):571-82. PubMed ID: 17827382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genomic analyses of bacteriophages targeting environmental and clinical CS3-expressing enterotoxigenic Escherichia coli (ETEC) strains.
    Chakraborty S; von Mentzer A; Begum YA; Manzur M; Hasan M; Ghosh AN; Hossain MA; Camilli A; Qadri F
    PLoS One; 2018; 13(12):e0209357. PubMed ID: 30571788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of Enteropathic Escherichia coli Species in Pediatric Patients at a Quaternary Children's Hospital.
    Nycz BT; Pretty K; Gomez-Trujillo A; Sanchez B; Dominguez SR
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):573-579. PubMed ID: 31803928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome Profiling of Enterotoxigenic Escherichia coli (ETEC) Carriers Highlights Signature Differences between Symptomatic and Asymptomatic Individuals.
    Higginson EE; Sayeed MA; Pereira Dias J; Shetty V; Ballal M; Srivastava SK; Willis I; Qadri F; Dougan G; Mutreja A
    mBio; 2022 Jun; 13(3):e0015722. PubMed ID: 35536001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteroaggregative Escherichia coli in diarrheic children in Egypt: molecular characterization and antimicrobial susceptibility.
    Ali MM; Ahmed SF; Klena JD; Mohamed ZK; Moussa TA; Ghenghesh KS
    J Infect Dev Ctries; 2014 May; 8(5):589-96. PubMed ID: 24820462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of verotoxin-producing Escherichia coli isolates in stool samples from patients with diarrhea.
    Usein CR; Tatu-Chiţoiu D; Palade AM; Ciontea S; Condei M; Nica M; Damian M
    Roum Arch Microbiol Immunol; 2008; 67(1-2):17-22. PubMed ID: 19284162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bacteriophages for prevention and treatment of diarrhea due to experimental enterotoxigenic Escherichia coli O149 infection of pigs.
    Jamalludeen N; Johnson RP; Shewen PE; Gyles CL
    Vet Microbiol; 2009 Apr; 136(1-2):135-41. PubMed ID: 19058927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Escherichia coli-Specific Bacteriophages and Polyvalent Bacteriophages in Piglet Guts with Increasing Coliphage Numbers after Weaning.
    Lin Y; Zhou B; Zhu W
    Appl Environ Microbiol; 2021 Aug; 87(17):e0096621. PubMed ID: 34160270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.